GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amicogen Inc (XKRX:092040) » Definitions » Short-Term Capital Lease Obligation

Amicogen (XKRX:092040) Short-Term Capital Lease Obligation : ₩644 Mil (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Amicogen Short-Term Capital Lease Obligation?

Amicogen's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩644 Mil.

Amicogen's quarterly Short-Term Capital Lease Obligation increased from Jun. 2023 (₩602 Mil) to Sep. 2023 (₩707 Mil) but then declined from Sep. 2023 (₩707 Mil) to Dec. 2023 (₩644 Mil).

Amicogen's annual Short-Term Capital Lease Obligation declined from Dec. 2021 (₩765 Mil) to Dec. 2022 (₩726 Mil) and declined from Dec. 2022 (₩726 Mil) to Dec. 2023 (₩644 Mil).

Amicogen Short-Term Capital Lease Obligation Historical Data

The historical data trend for Amicogen's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amicogen Short-Term Capital Lease Obligation Chart

Amicogen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,207.20 513.39 764.54 725.89 644.00

Amicogen Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 725.89 719.14 601.86 707.02 644.00

Amicogen Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Amicogen Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Amicogen's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Amicogen (XKRX:092040) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amicogen Inc (XKRX:092040) » Definitions » Short-Term Capital Lease Obligation
Comparable Companies
XKRX:000020 XKRX:005500 XKRX:102460 XKRX:084110 XKRX:058820 XKRX:007570 XKRX:001630 XKRX:096760 XKRX:293480 XKRX:102940 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
1259-64, Dongbu-ro, Gyeongsangnam-do, Jinseong-myeon, KOR, 660-852
Website
http://www.amicogen.com
Amicogen, Inc. is an industrial biotechnology company operating in Korea. It is engaged in development, production and distribution of enzymes, bio new materials and healthcare food. The company's products portfolio includes special enzymes, N-acetylglucosamine (NAG), pinitol, D-Chiro-inositol (DCI), collagen peptides (CP) and protein A chromatography resins.

Amicogen (XKRX:092040) Headlines

No Headlines